RCEL
NASDAQ
$4.19
AVITA Medical Inc (RCEL)
AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom. The company is headquartered in Valencia, California.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $7.23 (+72.55%)
Market Cap
$129M
Revenue 5Y CAGR
+56.90%
Free Cash Flow Yield
-25.61%
Beta (5Y)
1.39
Price Chart
Valuation
Market Cap$129M
Forward P/E10.29
P/S1.84
P/B11.77
Profitability
Total Revenue (TTM)$72M
Gross Profit (TTM)$59M
EBITDA-$37M
Profit Margin-55.7%
Operating Margin-46.2%
EPS-$1.53
Financial Health
Debt-to-Equity-199.2%
Free Cash Flow Yield-25.61%
Growth & Risk
EPS 5Y CAGR+15.82%
Revenue 5Y CAGR+56.90%
FCF 5Y CAGR+2.90%
Beta (5Y)1.39
Sharpe Ratio0.06